These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25421045)

  • 21. Cardiovascular therapy and pharmacogenetics in 2007.
    Carlquist J
    Pharmacogenomics; 2007 Jan; 8(1):21-3. PubMed ID: 17187505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of chronic cardiovascular drugs: applications and implications.
    Zineh I; Johnson JA
    Expert Opin Pharmacother; 2006 Aug; 7(11):1417-27. PubMed ID: 16859425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
    Roden DM
    Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiovascular diseases: present and future based on molecular biology].
    Oseguera Moguel J
    Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetics and cardiovascular disease: the impact of molecular diagnosis.
    Vengoechea J; McKelvey KD
    J Ark Med Soc; 2013 Apr; 109(11):230-2. PubMed ID: 23691714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics and drug response in cardiovascular disorders.
    Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S
    Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics and cardiovascular disease management.
    Weston CF
    Hosp Med; 2004 Oct; 65(10):594-8. PubMed ID: 15524338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular diagnosis for cardiovascular diseases].
    Schulze-Bahr E; Klaassen S; Abdul-Khaliq H; Schunkert H
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1538. PubMed ID: 26445261
    [No Abstract]   [Full Text] [Related]  

  • 30. [Update on the genetics of stroke].
    López Fernández JC; Rodríguez Esparragón F; Buset Ríos N
    Med Clin (Barc); 2014 Aug; 143(4):176-9. PubMed ID: 24703417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leveraging human genetics to guide drug target discovery.
    Stitziel NO; Kathiresan S
    Trends Cardiovasc Med; 2017 Jul; 27(5):352-359. PubMed ID: 27686272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 33. Use and interpretation of genetic tests in cardiovascular genetics.
    Caleshu C; Day S; Rehm HL; Baxter S
    Heart; 2010 Oct; 96(20):1669-75. PubMed ID: 20937756
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
    Joseph PG; Pare G; Ross S; Roberts R; Anand SS
    Clin Cardiol; 2014 Jan; 37(1):48-56. PubMed ID: 24105892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics and the treatment of cardiovascular disease.
    Wilkins MR; Roses AD; Clifford CP
    Heart; 2000 Oct; 84(4):353-4. PubMed ID: 10995394
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Evaluation, Familial Screening and Exercise.
    Stein R; Trujillo JP; Silveira ADD; Lamounier Júnior A; Iglesias LM
    Arq Bras Cardiol; 2017 Mar; 108(3):263-270. PubMed ID: 28273199
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics, genomics, proteomics: what is a cardiologist to do?
    Califf RM
    Am Heart J; 2000 Oct; 140(4):S48-50. PubMed ID: 11011324
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic tests become available for some cardiovascular diseases. Screening may help determine a family member's heart risk, but counseling is important to help patients make good decisions.
    Heart Advis; 2009 Jun; 12(6):5. PubMed ID: 19653371
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrated Biomarkers in Cardiovascular Disease - Third International Symposium.
    Wu A
    IDrugs; 2008 Sep; 11(9):636-8. PubMed ID: 18763211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.